Skip to content

Adhesion of ecabet sodium in the form of enteric coated capsule to the surface of small intestine.

Adhesion of ecabet sodium in the form of enteric coated capsule to the surface of small intestine. - Ecabet sodium adhesion to small intestine

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000001801
Enrollment
5
Registered
2009-04-01
Start date
2009-04-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy volunteers

Interventions

Granule form of ecabet sodium Enteric coated capsule form of ecabet sodium

Sponsors

Keio University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Healthy volunteers with informed consent

Exclusion criteria

Exclusion criteria: 1. Organic disease(Reflux esophagitis, Peptic ulcer disease, Erosive gastritis) 2. Past history of GI resection surgery other than appendectomy. 3. Intestinal lesions such as Crohn's disease, Behcet disease. 4. Patients with pace maker or with other electric device in the body 5. NSAIDs user, Patients with severe stress conditions 6. Organic disease in brain, Depression and Schizophrenia 7. Alcoholics and Drug dependence 8. Hyperthyroidism 9. Severe heart, liver and kidney diseases or infectious diseases 10. Drug allergy for ecabet sodium 11. Expectant mother, Breast feeding mother 12. Drug (anti-secretory drugs, prokinetics, antacid, anti-cholinergic agents, tranquilizer, anti-depressant)users within a week before the entry. 13. Subjects recognized as not suitable to the test by doctor.

Design outcomes

Primary

MeasureTime frame
To compare the adhesive ability of ecabet sodium in the form of enteric coated capsule with that in the form of conventional granules to small intestine

Countries

Japan

Contacts

Public ContactHidekazu Suzuki, M.D., Ph.D.

Keio University School of Medicine Division of Gastroenterology and Hepatology, Department of Internal Medicine

hsuzuki@sc.itc.keio.ac.jp03-5363-3914

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026